Simvastatin modulates the Alzheimer's disease-related gene seladin-1

Journal of Alzheimer's Disease

Volumn 28, Issue 2, 2012, Pages 297-301

  Ramos, Maria C ^a   Sierra, Saleta ^a   Ramirez, Carlos ^a   Velasco, Javier ^a   Burgos, Javier S ^a  

^a BioPharma Division   (Spain)

Author keywords

Alzheimer's disease; brain; cholesterol; neuroprotection; seladin 1; simvastatin

Indexed keywords

SIMVASTATIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELADIN 1 GENE; UPREGULATION;

EID: 84857022703     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111118     Document Type: Article

References (15)

1. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegener-ation and oxidative stress. J Neurosci 20, 7345-7352.
2. Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puolivali J, Salminen A, Helisalmi S, Soininen H (2002) Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 113, 301-310. (Pubitemid 34786175)
3. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T, SeoH (2008) 3beta-Hydroxysteroid-delta24 reductase isa hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 149, 3267-3273. (Pubitemid 351919585)
4. Zambon D, Quintana M, Mata P, Alonso R, Benavent J, Cruz-Sanchez F, Gich J, Pocovi M, Civeira F, Capurro S, Bachman D, Sambamurti K, Nicholas J, Pappolla MA (2010) Higher incidence of mild cognitive impairment in familial hyperc-holesterolemia. Am J Med 123, 267-274.
5. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 163, 1053-1057. (Pubitemid 36548931)
6. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer's disease: the cholesterol connection. Nat Neurosci 6, 345-351. (Pubitemid 36373979)
7. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsub-ara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hyperc-holesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61, 199-205. (Pubitemid 36875301)
8. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7, 321-331.
9. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC (2002) Diet-induced hypercholesterolemia enhances brain a beta accumulation in transgenic mice. Neuroreport 13, 455-459. (Pubitemid 34293189)
10. Ramirez C, Sierra S, Tercero I, Vazquez JA, Pineda A, Manrique T, Burgos JS (2011) ApoB100/LDLR-/- hyper-cholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. PLoS One 6, e22712.
11. Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 8, 890-899. (Pubitemid 33055603)
12. Sparks DL, Kryscio RJ, Sabbagh MN, Connor DJ, Sparks LM, Liebsack C (2008) Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res 5, 416-421.
13. Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Bre-itner JC, Larson EB (2010) Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc 58, 1311-1317.
14. Sierra S, Ramos MC, Molina P, Esteo C, Vazquez JA, Burgos JS (2011) Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 23, 307-318.
15. Ramirez C, Tercero I, Pineda A, Burgos JS (2011) Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment. J Alzheimers Dis 24, 161-174.